HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

RNA Therapeutics For Cancer

RNA Therapeutics For Cancer

RNA therapeutics represent a promising frontier in cancer research, offering targeted treatment options with potential for fewer side effects. These therapies utilize various RNA molecules, including messenger RNA (mRNA), small interfering RNA (siRNA), and microRNA (miRNA), to regulate gene expression or directly target cancer cells. mRNA vaccines, like those developed for COVID-19, stimulate the immune system to recognize and attack cancer-specific antigens. siRNA molecules can silence oncogenes or block proteins essential for tumor growth. Additionally, miRNAs regulate gene expression and control cellular processes implicated in cancer progression. By harnessing the power of RNA, researchers aim to develop precise, personalized treatments that disrupt cancer pathways while sparing healthy tissues. As this field advances, RNA therapeutics hold immense potential to revolutionize cancer care, offering hope for more effective and tailored treatment strategies.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp